NCT03367065

Brief Summary

This feasibility study has therefore several aims:

  1. 1.construct a dedicated CT perfusion protocol for GIT wall perfusion;
  2. 2.used a two-compartment pharmacokinetic model which is more adapted that a unique compartment model;
  3. 3.from the image acquired, evaluate current parameters of perfusion including the permeability ones

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 8, 2017

Completed
Last Updated

April 13, 2020

Status Verified

April 1, 2020

Enrollment Period

1.1 years

First QC Date

August 26, 2016

Last Update Submit

April 10, 2020

Conditions

Mesenteric IschemiaPermeability CT Technics

Outcome Measures

Primary Outcomes (1)

  • number of computerised tomography with interpretable data

    2 hours

Study Arms (1)

Dynamic contrast enhanced computerised tomography

EXPERIMENTAL
Radiation: Dynamic contrast enhanced computerised tomography

Interventions

Dynamic contrast enhanced computerised tomographyRADIATION
Dynamic contrast enhanced computerised tomography

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all patients over fifty years old with clinico-biological suspicion for acute GITischemia admitted at our institution

You may not qualify if:

  • contra-indication to contrast agent injection as so defined by the European Society of UroRadiology in 2014
  • inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Poitiers

Poitiers, Aquitaine, 86000, France

Location

MeSH Terms

Conditions

Mesenteric Ischemia

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesPeritoneal DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Guillaume HERPE, MD

    CHU Poitiers

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2016

First Posted

December 8, 2017

Study Start

October 1, 2016

Primary Completion

November 1, 2017

Study Completion

December 1, 2017

Last Updated

April 13, 2020

Record last verified: 2020-04

Locations

FR(1)